Results for tag: "Hypersomnia Drug"

The Hypersomnia Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat excessive sleepiness, such as narcolepsy, idiopathic hypersomnia, and obstructive sleep apnea. These drugs are typically stimulants, such as modafinil, armodafinil, and methylphenidate, and are used to increase alertness and reduce fatigue. Other drugs used to treat hypersomnia include sodium oxybate, which is used to reduce cataplexy, and antidepressants, which are used to reduce the symptoms of depression. Some companies in the Hypersomnia Drug market include Cephalon, Inc., Jazz Pharmaceuticals, Inc., and Sunovion Pharmaceuticals, Inc. Show Less Read more